Wednesday, February 7, 2024

The Covid Vaccines Are Safe And Effective--Updated

Just a few articles that caught my attention:

    The Springer Nature medical journal Cureus, sibling to Nature and Scientific American, published a peer-reviewed paper by high-profile mRNA vaccine critics last month, showing the growing mainstream openness to data and arguments once nitpicked if not ignored by publishers and suppressed by academia and Big Tech.

    The feds have struggled to keep interest high in each new formulation of the COVID vaccines, with fewer than 12% of minors, 22% of adults and just 41% of those 65 and up taking the 2023-2024 vaccines, according to the latest weekly National Immunization Survey.

    The dam of The Science, which once limited the flow of research questioning the integrity of trial data and wisdom of one-size-fits-all vaccination recommendations to a trickle, now struggles to stop a worldwide deluge as new cracks emerge seemingly every week.

    While early reports from the mRNA trials said the novel vaccines "could greatly reduce COVID-19 symptoms," re-analysis of Pfizer's trial data "identified statistically significant increases" in serious adverse events (SAEs) in the intervention group, which then became unmistakable after emergency use authorization, the Cureus paper says.

    "The risk-benefit imbalance substantiated by the evidence to date contraindicates further booster injections and suggests that, at a minimum, the mRNA injections should be removed from the childhood immunization program until proper safety and toxicological studies are conducted," the paper also states.

    U.S. approval of mRNA vaccines "on a blanket-coverage population-wide basis had no support from an honest assessment of all relevant registrational data and commensurate consideration of risks versus benefits," the authors wrote.

    They include multiple cancelation targets: cardiologist Peter McCullough, MIT senior research scientist Stephanie Seneff, vaccine researcher Jessica Rose, and tech entrepreneur and Vaccine Safety Research Foundation founder Steve Kirsch, a philanthropist once courted by Democratic presidential hopefuls.

    The feds were so concerned about one of those SAEs, heart inflammation, that the Centers for Disease Control and Prevention drafted an alert about a surprisingly high number of post-vaccination myocarditis reports to send to its Health Alert Network.

    HAN is the agency's "primary method of sharing cleared information about urgent public health incidents with public information officers; federal, state, territorial, tribal, and local public health practitioners; clinicians; and public health laboratories," it says.

    The myocarditis alert was never sent, however, apparently out of fear of spooking the public, according to The Epoch Times, which posted a 1,433-page batch of heavily redacted emails it obtained. It said the two-page draft alert was completely redacted.

 The article goes on to discuss the uptick in cancers following vaccination.

    Our understanding of COVID-19 vaccinations and their impact on health and mortality has evolved substantially since the first vaccine rollouts. Published reports from the original randomized phase 3 trials concluded that the COVID-19 mRNA vaccines could greatly reduce COVID-19 symptoms. In the interim, problems with the methods, execution, and reporting of these pivotal trials have emerged.

    Re-analysis of the Pfizer trial data identified statistically significant increases in serious adverse events (SAEs) in the vaccine group. Numerous SAEs were identified following the Emergency Use Authorization (EUA), including death, cancer, cardiac events, and various autoimmune, hematological, reproductive, and neurological disorders. Furthermore, these products never underwent adequate safety and toxicological testing in accordance with previously established scientific standards.

    Among the other major topics addressed in this narrative review are the published analyses of serious harms to humans, quality control issues and process-related impurities, mechanisms underlying adverse events (AEs), the immunologic basis for vaccine inefficacy, and concerning mortality trends based on the registrational trial data.

    The risk-benefit imbalance substantiated by the evidence to date contraindicates further booster injections and suggests that, at a minimum, the mRNA injections should be removed from the childhood immunization program until proper safety and toxicological studies are conducted.

    Federal agency approval of the COVID-19 mRNA vaccines on a blanket-coverage population-wide basis had no support from an honest assessment of all relevant registrational data and commensurate consideration of risks versus benefits.

    Given the extensive, well-documented SAEs and unacceptably high harm-to-reward ratio, we urge governments to endorse a global moratorium on the modified mRNA products until all relevant questions pertaining to causality, residual DNA, and aberrant protein production are answered.

    I have previously reported on my concern about the rise in stable cancer relapses that I have witnessed in my melanoma clinic.

    None of these patients of mine presented with the classic prodrome of relapse that I had always noticed previously, such as severe depression due to bereavement, divorce or bankruptcy. Indeed the only thing I found they had in common was to have had a recent booster mRNA covid vaccine. I phoned around my colleagues not only in the UK but also in Australia to check their experience. In no case did they deny such a link. Indeed, they were equally alarmed at the association between booster vaccines and relapse that they too were witnessing, as well an increase in new cancers, particularly in those below 50 years old. In addition to melanoma these colleagues were also very concerned about a sudden big increase in young patients with colorectal cancer.

    Rather than instigating a proper inquiry to investigate this when we raised these concerns, the medical authorities told us all that what we were witnessing was a coincidence, that we had to prove it and above all, not to upset our patients.

    Recently the American Cancer Society (ACS) has warned of a surge in new cancer cases in the US this lastyear of over 2million, with many of these cases occurring in younger patients. Indeed, the chief scientific officer of the ACS, William Dahat, announced in addition that cancers were presenting with more aggressive disease and larger tumours at the time of diagnosis, especially in younger patients. ...

    This surge mirrors a report from Phinance Technologies of late last year which analysed in detail data from the UK Office for National Statistics (ONS) which showed that disability and deaths in 2021 and 2022 had increased dramatically in all age groups, but especially in the 15-44 age group.

    The Lancet also published an article before Christmas reporting excess deaths post covid pandemic to be up by 11-15 per cent over than expected for under-25s and for between 25-49 year olds. This is in fact the pattern found in many countries that have looked at the data. Germany for example has reported excess deaths rising from 7 per cent in 2020 to 24 per cent in 2023. 

    What makes this all the more surprising is that negative deaths should be the norm after a pandemic as you cannot die twice!

Read the whole thing. 

No comments:

Post a Comment

Weekend Reading

 First up, although I'm several days late on this, Jon Low posted a new Defensive Pistolcraft newsletter on 12/15/2024 . He includes thi...